PROTAC erf3a Degrader-1 - HY-163938
Nur noch %1 verfügbar
Catalog #
HY-163938
Ab
620,00 €
PROTAC erf3a Degrader-1 (Compound C63) is an orally active PROTAC erf3a Degrader. PROTAC erf3a Degrader-1 inhibits cancer cell proliferation (eg: 22Rv1). PROTAC erf3a Degrader-1 can be used for research of prostate cancer, ovarian cancer, liver cancer, cervical cancer, leukemia, breast cancer. (Red: erf3a ligand (HY-13778); Black: linker (HY-163960); Blue: CRBN ligand (HY-41547))[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-163938/PROTAC-erf3a-Degrader-1-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Blue Ice |
| Application | Cancer-programmed cell death |
| CAS | 3033871-19-8 |
| Storage | -20°C (Powder, protect from light, stored under nitrogen) |
| MWT | 760.92 |
| Solubility | DMSO : 60 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | PROTACs |
| Application: | Cancer-programmed cell death |
|---|